157 related articles for article (PubMed ID: 26587148)
1. [Epidermal necrolysis linked to the dermal application of a potassium hydroxide solution].
Korsaga-Somé N; Tapsoba P; Ouédraogo MS; Ilboudo LB; Barro-Traoré F; Niamba P; Traoré A
Pan Afr Med J; 2015; 21():299. PubMed ID: 26587148
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of 5% and 2.5% potassium hydroxide solution for molluscum contagiosum in children.
Uçmak D; Akkurt MZ; Kacar SD; Sula B; Arica M
Cutan Ocul Toxicol; 2014 Mar; 33(1):54-9. PubMed ID: 23713782
[TBL] [Abstract][Full Text] [Related]
3. Acute ulceronecrotic adverse reaction to potassium hydroxide 5% solution in the treatment of molluscum contagiosum.
Bresesti I; Ciolfi C; Rotatore G; Borisov AN; Zuccotti GV; Brazzelli V
Pediatr Dermatol; 2020 Jan; 37(1):224-225. PubMed ID: 31625620
[TBL] [Abstract][Full Text] [Related]
4. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
East-Innis AD; Thompson DS
West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
[TBL] [Abstract][Full Text] [Related]
5. Potassium hydroxide 5% for the treatment of molluscum contagiosum.
Drug Ther Bull; 2014 Oct; 52(10):118-20. PubMed ID: 25298120
[TBL] [Abstract][Full Text] [Related]
6. Toxic epidermal necrolysis. A widespread, life-threatening blistering reaction.
Watanakunakorn P; Brodell RT
Postgrad Med; 2000 Apr; 107(4):29-30. PubMed ID: 10778408
[No Abstract] [Full Text] [Related]
7. Double-blind, randomized, placebo-controlled trial of the use of topical 10% potassium hydroxide solution in the treatment of molluscum contagiosum.
Short KA; Fuller LC; Higgins EM
Pediatr Dermatol; 2006; 23(3):279-81. PubMed ID: 16780480
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous artifactual disease represented as recurrent toxic epidermal necrolysis.
Gowring LE; Johnson R; Hivnor CM; Henning JS
Cutis; 2016 Sep; 98(3):E6-E7. PubMed ID: 27814420
[No Abstract] [Full Text] [Related]
9. Trimethoprim-sulfamethoxazole-induced Stevens-Johnson syndrome: a case report.
Langlois MR; Derk F; Belczyk R; Zgonis T
J Am Podiatr Med Assoc; 2010; 100(4):299-303. PubMed ID: 20660883
[TBL] [Abstract][Full Text] [Related]
10. Toxic epidermal necrolysis due to cotrimoxazole.
Lipozencic J; Milavec-Puretic V; Kotrulja L; Tomicic H; Stulhofer Buzina D
J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):182-3. PubMed ID: 12046835
[No Abstract] [Full Text] [Related]
11. Patch testing in an unusual case of toxic epidermal necrolysis.
Klein CE; Trautmann A; Zillikens D; Bröcker EB
Contact Dermatitis; 1996 Sep; 35(3):175-6. PubMed ID: 8930481
[No Abstract] [Full Text] [Related]
12. Patch testing in an unusual case of toxic epidermal necrolysis.
Klein CE; Trautmann A; Zillikens D; Bröcker EB
Contact Dermatitis; 1995 Dec; 33(6):448-9. PubMed ID: 8706422
[No Abstract] [Full Text] [Related]
13. Co-trimoxazole for toxic epidermal necrolysis in AIDS.
Senneville E; Lecocq P; Ajana F; Chidiac C; Mouton Y
Lancet; 1991 Apr; 337(8746):919. PubMed ID: 1672997
[No Abstract] [Full Text] [Related]
14. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Wildermuth A
JAAPA; 2020 Aug; 33(8):48-49. PubMed ID: 32740115
[No Abstract] [Full Text] [Related]
15. Bullous fixed drug eruption masquerading as recurrent Stevens Johnson syndrome.
Dharamsi FM; Michener MD; Dharamsi JW
J Emerg Med; 2015 May; 48(5):551-4. PubMed ID: 25433836
[TBL] [Abstract][Full Text] [Related]
16. Fatal toxic epidermal necrolysis probably related to glimepiride in a patient with a medical history of hypersensitivity to sulfamethoxazole-trimethoprim.
Ouni B; Fathallah N; Ben-Sayed N; Abdessayed N; Slim R; Sriha B; Ben Salem C
Br J Clin Pharmacol; 2021 Mar; 87(3):1591-1593. PubMed ID: 32815205
[No Abstract] [Full Text] [Related]
17. [An unusual hemorrhagic variant of Stevens-Johnson syndrome in an HIV-infected patient].
Schmid MH; Elsner P
Hautarzt; 1999 Jan; 50(1):52-5. PubMed ID: 10068933
[TBL] [Abstract][Full Text] [Related]
18. A large population-based follow-up study of trimethoprim-sulfamethoxazole, trimethoprim, and cephalexin for uncommon serious drug toxicity.
Jick H; Derby LE
Pharmacotherapy; 1995; 15(4):428-32. PubMed ID: 7479194
[TBL] [Abstract][Full Text] [Related]
19. Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS.
Darlenski R; Kazandjieva J; Tsankov N
Clin Dermatol; 2015; 33(5):538-41. PubMed ID: 26321400
[TBL] [Abstract][Full Text] [Related]
20. Stevens-Johnson Syndrome in a Patient on Concomitant Treatment with Levetiracetam and Trimethoprim/Sulfamethoxazole.
Tabet Aoul A; Al-Nasseri A; Hall C; He C; Abernathy J
Am J Case Rep; 2024 Jan; 25():e942982. PubMed ID: 38247161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
